Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00091325 · ClinicalTrials.gov registry record · Phase 1

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

A Phase 1 study, sponsored by University of Arizona.

Completed
Registry status
Phase 1
Development phase

NCT00091325: Completed Phase 1 study, sponsored by University of Arizona.

NCT00091325 is a Phase 1 study that has completed, run by University of Arizona. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00091325, a Phase 1 study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
Phase 1
Development phase

Study Summary

RATIONALE: Green tea extract (Polyphenon E) contains ingredients that may prevent the development of cancer. PURPOSE: This phase I trial is studying how well green tea extract works in preventing cancer in healthy participants.

Interventions

  • DIETARY_SUPPLEMENT defined green tea catechin extract

Trial Details

FieldValue
Start Date 2004-10
Phase Phase 1
University of Arizona

349 total trials

What the finished NCT00091325 record still lists

NCT00091325 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which defined green tea catechin extract is the first listed.

NCT00091325 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00091325 about?

NCT00091325 is a clinical study titled "Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants". RATIONALE: Green tea extract (Polyphenon E) contains ingredients that may prevent the development of cancer. PURPOSE: This phase I trial is studying how well green tea extract works in preventing cancer in healthy participants.

What is the current status of trial NCT00091325?

This trial is currently completed. It is a Phase 1 study. The study started on 2004-10.

What interventions are being tested in trial NCT00091325?

The interventions under investigation include: defined green tea catechin extract (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00091325?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00091325, the US trial registry maintained by the National Library of Medicine. NCT00091325 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.